UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 

 

SCHEDULE 14A

Proxy Statement Pursuant to Section 14(a) of the

Securities Exchange Act of 1934

(Amendment No.     )

 

 

Filed by the Registrant  ☒                             Filed by a party other than the Registrant  ☐

Check the appropriate box:

 

     
  Preliminary Proxy Statement
   
  Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
   
  Definitive Proxy Statement
   
  Definitive Additional Materials
   
  Soliciting Material Pursuant to §240.14a-12

TherapeuticsMD, Inc.

(Name of Registrant as Specified in its Charter)

 

(Name of Person(s) Filing Proxy Statement, if other than the Registrant)

Payment of Filing Fee (Check the appropriate box):

         
   
  No fee required.
   
  Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.
     
    1)  

Title of each class of securities to which transaction applies:

 

     

    2)  

Aggregate number of securities to which transaction applies:

 

     

    3)  

Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):

 

     

    4)  

Proposed maximum aggregate value of transaction:

 

     

    5)  

Total fee paid:

 

     

   
  Fee paid previously with preliminary materials.
   
  Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.
     
    1)  

Amount previously paid:

 

     

    2)  

Form, Schedule or Registration Statement No.:

 

     

    3)  

Filing party:

 

     

    4)  

Date Filed:

 

     

   

   
 

***  Exercise Your Right to Vote  ***

Important Notice Regarding the Availability of Proxy Materials for the
Stockholder Meeting to Be Held on June 25, 2018.

           
    Meeting Information  
THERAPEUTICSMD, INC.  

Meeting Type:       Annual Meeting

 
    For holders as of: April 26, 2018  
    Date: June 25, 2018      Time: 8:00 a.m., Local Time  
    Location:

Renaissance Boca Raton Hotel
2000 NW 19th Street
Boca Raton, Florida 33431

 

 
       
(LOGO)    You are receiving this communication because you hold shares in the company named above.  

THERAPEUTICSMD, INC.
6800 BROKEN SOUND PKWY NW, THIRD FLOOR
BOCA RATON, FL 33487

 

 

This is not a ballot. You cannot use this notice to vote these shares. This communication presents only an overview of the more complete proxy materials that are available to you on the Internet. You may view the proxy materials online at www.proxyvote.com or easily request a paper copy (see reverse side).

 

We encourage you to access and review all of the important information contained in the proxy materials before voting.

 
       
    See the reverse side of this notice to obtain proxy materials and voting instructions.  

 

E44351-P07387

 

 
 

 

      Before You Vote      
       

How to Access the Proxy Materials 

                   
    Proxy Materials Available to VIEW or RECEIVE:  
    NOTICE AND PROXY STATEMENT     FORM 10-K    
   

How to View Online:

Have the information that is printed in the box marked by the arrow (GRAPHIC) XXXX XXXX XXXX XXXX (located on the following page) and visit: www.proxyvote.com.

 
       
   

How to Request and Receive a PAPER or E-MAIL Copy:

If you want to receive a paper or e-mail copy of these documents, you must request one. There is NO charge for requesting a copy. Please choose one of the following methods to make your request:

 
      1) BY INTERNET: www.proxyvote.com  
      2) BY TELEPHONE: 1-800-579-1639  
      3) BY E-MAIL*: sendmaterial@proxyvote.com  
    * If requesting materials by e-mail, please send a blank e-mail with the information that is printed in the box marked by the arrow (GRAPHIC) XXXX XXXX XXXX XXXX (located on the following page) in the subject line.  
   

Requests, instructions and other inquiries sent to this e-mail address will NOT be forwarded to your investment advisor. Please make the request as instructed above on or before June 11, 2018 to facilitate timely delivery.

 

 
     

 

      How To Vote      
       

Please Choose One of the Following Voting Methods

       
    Vote In Person: Many stockholder meetings have attendance requirements including, but not limited to, the possession of an attendance ticket issued by the entity holding the meeting. Please check the meeting materials for any special requirements for meeting attendance. At the meeting, you will need to request a ballot to vote these shares.  
       
    Vote By Internet: To vote now by Internet, go to www.proxyvote.com. Have the information that is printed in the box marked by the arrow (GRAPHIC) XXXX XXXX XXXX XXXX (located on the following page) available and follow the instructions.  
       
    Vote By Mail: You can vote by mail by requesting a paper copy of the materials, which will include a proxy card.  
       
       

 

E44352-P07387

 

 
 

 

         
Voting Items    
     
The Board of Directors recommends you vote FOR the following:  
     
1.

Election of Directors

 
     
  Nominees:  
     

  01) Tommy G. Thompson 07) Robert V. LaPenta, Jr.
  02) Robert G. Finizio 08) Jules A. Müsing
  03) John C.K. Milligan, IV 09) Angus C. Russell
  04) Brian Bernick 10) Jane F. Barlow
  05) J. Martin Carroll 11) Nicholas Segal
  06) Cooper C. Collins    

 

The Board of Directors recommends you vote FOR the following proposals:
   
2. To approve, on a non-binding advisory basis, the compensation of our named executive officers for the fiscal year ended December 31, 2017 (say-on-pay);
   
3. To ratify the appointment of Grant Thornton LLP, an independent registered public accounting firm, as the independent auditor of our company for the fiscal year ending December 31, 2018;

 

and upon such other business as may properly come before the meeting or any adjournment thereof.

 

E44353-P07387

 

 

 

 

  

 

 

 

 

 

 

 

 

 

 

 

 

 

E44354-P07387